NEJM — Recent Cardiology Articles- Seeing the Left Main Coronary Artery Clearly — Is IVUS Always Necessary? March 30, 2026Treatment of the left main coronary artery with percutaneous coronary intervention (PCI) in the absence of previous surgical revascularization, also referred to as an unprotected left main coronary artery PCI, is one of the riskier tasks that interventional cardiologists are asked to perform. Stent implantation in the left main coronary...
- Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease March 30, 2026Among patients with infrainguinal artery disease who were undergoing angioplasty, the risk of major adverse limb events at 1 year was lower with sirolimus-coated balloons than with uncoated balloons, and mortality was similar.
- IVUS — A Zigzag Path to Success March 30, 2026The use of intravascular ultrasound (IVUS) imaging for assessment of the coronary arteries has an almost 40-year history. In an editorial comment on an early ex vivo assessment of the accuracy of IVUS in evaluating human coronary arteries, Yock and Linker1 posed three questions that remain relevant today:...
- Sirolimus-Eluting Technology for the Treatment of Peripheral Artery Disease March 30, 2026Patients with advanced peripheral artery disease often undergo either surgical or endovascular revascularization for the treatment of lifestyle-limiting claudication or nonhealing lower-limb wounds. Major limitations of endovascular intervention include the high incidence of restenosis and the need for repeat intervention with standard balloon angioplasty. During the past decade, the use...
- Discontinuation of Beta-Blocker Therapy after Myocardial Infarction March 30, 2026Among patients with a preserved ejection fraction at least 1 year after myocardial infarction, stopping beta-blockers was noninferior to continuing therapy with respect to major clinical outcomes.
- Seeing the Left Main Coronary Artery Clearly — Is IVUS Always Necessary? March 30, 2026
